1. Cognition and Other Non-Motor Symptoms in an At-Risk Cohort for Parkinson’s Disease Defined by REM-Sleep Behavior Disorder and Hyposmia
- Author
-
Pauly, Laure, Rauschenberger, Armin, Pauly, Claire, Schröder, Valerie E., Van Cutsem, Gilles, Leist, Anja K., and Krüger, Rejko
- Abstract
Background: REM-sleep behavior disorder (RBD) and other non-motor symptoms such as hyposmia were proposed by the Movement Disorder Society as research criteria for prodromal Parkinson’s disease (P-PD). Global cognitive deficit was later added.Objective: To compare non-motor symptoms, focusing on cognition, between a P-PD group and a matched control group.Methods: In this cross-sectional, case-control study, in a first set of analyses, we performed extensive cognitive testing on people with (n?=?76) and a control group without (n?=?195) probable RBD and hyposmia. Furthermore, we assessed motor and non-motor symptoms related to Parkinson’s Disease (PD). After propensity score matching, we compared 62 P-PD with 62 age- and sex-matched controls. In addition, we performed regression analyses on the total sample (n?=?271). In a second set of analyses, we used, a.o., the CUPRO to evaluate retrograde procedural memory and visuo-constructive functions.Results: People with P-PD showed significantly poorer performances in global cognition, visuo-constructive and executive functions, mainly in mental flexibility (p?0.001; p?=?0.004; p?=?0.003), despite similar educational levels (p?=?0.415). We observed significantly more motor and non-motor symptoms (p?0.001; p?=?0.004), higher scores for depression (p?=?0.004) and apathy (p?0.001) as well as lower quality of life (p?0.001) in P-PD.CONCLUSIONS: Our findings confirm that global cognitive, executive, and visuo-constructive deficits define the P-PD group. In addition, depression, apathy, and lower quality of life were more prevalent in P-PD. If replicated in other samples, executive and visuo-constructive deficits should be considered in non-motor P-PD. Determining specific patterns will support early recognition of PD, secondary prevention of complications and the development of neuroprotective treatments.
- Published
- 2024
- Full Text
- View/download PDF